NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $704,314 | -0.8% | 6,915 | -1.7% | 0.16% | +6.1% |
| Q2 2023 | $709,959 | +7.8% | 7,036 | -1.7% | 0.15% | +9.6% |
| Q1 2023 | $658,839 | +80739.1% | 7,161 | -20.3% | 0.14% | -22.9% |
| Q4 2022 | $815 | -99.9% | 8,980 | +15.9% | 0.18% | +20.7% |
| Q3 2022 | $589,000 | -18.3% | 7,745 | -9.2% | 0.14% | -16.2% |
| Q2 2022 | $721,000 | -1.6% | 8,526 | +2.1% | 0.17% | -6.5% |
| Q1 2022 | $733,000 | +46.0% | 8,354 | +45.6% | 0.18% | +46.8% |
| Q4 2021 | $502,000 | -16.6% | 5,737 | -22.1% | 0.13% | -25.0% |
| Q3 2021 | $602,000 | +96.7% | 7,361 | +119.7% | 0.17% | +100.0% |
| Q2 2021 | $306,000 | +39.7% | 3,351 | +31.2% | 0.08% | -11.6% |
| Q3 2017 | $219,000 | +9.0% | 2,554 | +6.2% | 0.10% | +4.4% |
| Q2 2017 | $201,000 | -16.2% | 2,406 | -7.7% | 0.09% | -36.4% |
| Q3 2015 | $240,000 | – | 2,608 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |